Pursue a PhD in Health Economics at @LSEnews with full funding, a £1,600 monthly stipend, and hands-on experience at OHE. Apply by 25 April 2025! Apply today: https://t.co/A9y9uiBhrn
Want to gain the skills and knowledge to build and assess decision models? Explore Foundations and Advanced online on-demand short courses in 'Decision Modelling for Health Economic Evaluation' with @CHEyork and @LSHTM_GHECO. Available to book now at https://t.co/FXZWNLfdKU
Join us next Monday as Best Practices in Health Preference Research continues with Webinar #3. Learn how to present decision objects, define attributes & levels, and improve your HPR study design. Don't miss it - Register now: https://t.co/q8oPjDoc4L
Everybody talked about and to some extent admired Daron Ace during my PhD, because he is the king of publication on top 5 econ journals. It seems so easy for him to publish top 5…I think he is well deserved the Nobel.
Discussions on the award of the Nobel Prize in economics to Acemoglu, Johnson, and Robinson have often focused on their empirical papers on economic growth.
A🧵 to point to the big picture: how they transformed the discipline.
The most interesting finding: Although hospital-based monitoring is generally preferred, patients with prior experience in community services actually prefer community based monitoring, suggesting that experience and familiarity play roles here
Our recent article with colleagues from @HERU_Abdn investigates patients’ preferences for alternative ways of ocular hypertension monitoring using a choice experiment https://t.co/wY0Fq3Idkb
Check our recent paper with colleagues in @HERU_Abdn
and other institutions assessed the cost-effectiveness of making treatment decisions for ocular hypertension patients based on a risk prediction tool in the UK
https://t.co/cD3aRqar0i
@HERU_Abdn We simulated individual patients from a rick dataset containing 5000+ patients from electronic medical records using a novel discrete event simulation model. The results suggest that risk prediction strategy had a 96% probability of being cost effective
A new paper is out today, exploring the innovative use of technology to enhance stated preference studies @gemmaeshields @CarolineMVass@ocramireob
Follow the link for full paper...
https://t.co/DihX9iSkKT
New paper out!
Habe you ever wondered how to incorporate resource scarcity in the elicitation of preferences for resource allocations? Or have you ever wanted to conduct a discrete-continuous choice experiment? Then perhaps PVE is of interest to you! https://t.co/QUEf7NzZKO
The December 2023 issue of the HERU newsletter has been published, with updates on the GRIP project on glaucoma monitoring and a study on reducing drug deaths. Also, new research to prevent threatened miscarriage, and dates for our 2024 DCE courses - https://t.co/iiu09e4Jl2
Another great presentation from one of our @hsru_aberdeen @MRCTMRPDTP#PhD students. This time @frankskyou doing a great job of outlining plans for his next 3 years of using behavioural science to support design and delivery of greener trials.
New current opinion “Role Preferences in Medical Decision Making: Relevance and Implications for Health Preference Research" https://t.co/S8r3f9NRWI
@JaninevanTil & colleagues give 3 recommendations on how role preferences can be elicited and integrated with health preferences. https://t.co/HmqaS3JcN1
Funded PhD studentships in clinical trials methodology available from @MRCNIHRTMRP - including a project @HERU_Abdn on 'Optimising the collection and use of health economic data within trials'. More details at https://t.co/VZ12QQH6Uh Closing date 15 Jan 2024.
“Behavioral Economics to Inform #Healthcare Decisions,” a spotlight session at #ISPOREurope, will offer an overview of #behavioraleconomics and examples of how its applications can inform #treatmentdecisions & improve outcomes within chronic diseases. https://t.co/1B366xKaCg
The course is taught online by HERU staff and no experience of health economics is needed to join. It is also part of out Postgraduate Programme in Health Economics for Health Professionals and is now available as a standalone option.